FIELD: medicine, pharmaceutical industry.
SUBSTANCE: invention relates to new high-manufacturing technologies allowing to prepare immunotropic sterile high-quality safe medicinal preparations based on deoxyribonucleate sodium prepared from defatted milt of sturgeon and salmon fishes, calf thymus, chicken blood. Invention provides enhancing the therapeutic effectiveness of the preparation and reducing ecological loading in manufacturing the claimed preparation.
EFFECT: improved producing method.
1 tbl, 1 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF APYROGENIC IMMUNOMODULATING AGENT | 2006 |
|
RU2309759C1 |
METHOD FOR PRODUCTION OF MEDICINAL PRODUCT BASED ON SODIUM DEOXYRIBONUCLEATE | 2020 |
|
RU2749007C1 |
PROCESS OF PRODUCTION OF SODIUM DNA SALT FROM ANIMAL RAW MATERIAL AND BIOREACTOR FOR ITS REALIZATION | 1993 |
|
RU2005724C1 |
METHOD OF PREPARING IMMUNOTROPIC ANTIVARAL DRUG | 2000 |
|
RU2172632C1 |
METHOD OF PRODUCING ANTIVIRAL DRUG | 2020 |
|
RU2739186C1 |
METHOD OF DNA SODIUM SALT ISOLATION | 1990 |
|
RU2017496C1 |
METHOD OF MANUFACTURE OF STERILE PHARMACEUTICAL SUBSTANCE | 2018 |
|
RU2673802C1 |
DERINAT SUPPOSITORIES TO BE USED IN MEDICAL PRACTICE | 2009 |
|
RU2429854C2 |
METHOD OF PREPARING DNA SODIUM SALT FROM FISH MILT | 1995 |
|
RU2072855C1 |
PROCESS FOR SODIUM PREPARING SALT POWDER OF DEOXYRIBONUCLEIC ACID FROM MILT | 1993 |
|
RU2041885C1 |
Authors
Dates
2004-09-27—Published
2003-12-30—Filed